Cart
sales@molnova.com
NBD-14189
CAS No.
NBD-14189 ( NBD14189 )
Catalog No. M17095 CAS No.
NBD-14189 (NBD14189) is a novel potent HIV-1 entry antagonist with potency as low as 63nM against some clinical isolates.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNBD-14189
-
NoteResearch use only, not for human use.
-
Brief DescriptionNBD-14189 (NBD14189) is a novel potent HIV-1 entry antagonist with potency as low as 63nM against some clinical isolates.
-
DescriptionNBD-14189 (NBD14189) is a novel potent HIV-1 entry antagonist with potency as low as 63nM against some clinical isolates, target HIV-1 gp120.
-
SynonymsNBD14189
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number--
-
Formula Weight428.41
-
Molecular FormulaC18H16F4N4O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameN-(2-amino-1-(4-(hydroxymethyl)thiazol-2-yl)ethyl)-5-(3-fluoro-4-(trifluoromethyl)phenyl)-1H-pyrrole-2-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Curreli F, et al. Eur J Med Chem. 2018 Jun 25;154:367-391.
molnova catalog
related products
-
HIV-1 Nef-IN-1
HIV-1 Nef-IN-1 is an inhibitor of HIV-1 Nef protein. It efficiently competes for Nef-SH3Hck interactions(Kd : 6.7 μM).
-
I-XW-053
I-XW-053 is an inhibitor of capsid targeted HIV-1 replication using the hybrid structure based method to block the interface between CA N-terminal domains (NTD-NTD interface) with micromolar affinity.
-
DRB
DRB is a nucleoside analog that inhibits several carboxyl-terminal domain (CTD) kinases including casein kinase II (IC50 range of 4-10 μM).
